The T cell activation marker CD150 can be used to identify alloantigen-activated CD4+25+ regulatory T cells

被引:15
作者
Browning, MB [1 ]
Woodliff, JE
Konkol, MC
Pati, NT
Ghosh, S
Truitt, RL
Johnson, BD
机构
[1] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[2] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA
关键词
CD4(+)25(+) cells; CD150; human regulatory T cells; graft vs. host disease;
D O I
10.1016/j.cellimm.2004.03.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have been investigating whether alloantigen-specific CD4(+)25(+) regulatory T cells can be identified for use in treating graft-versus-host disease. CD 150, which is upregulated on the surface of all activated T lymphocytes, was identified as a candidate marker for alloantigen-activated CD4(+)25(+) regulatory T cells by gene chip analysis. Freshly isolated CD4(+)25(+) cells had only low cell-surface expression of CD150. comparable to that of CD4(+)25(-) T cells. Increased CD150 expression was observed on all T cells after coculture with allogeneic stimulator cells. When Purified CD4(+)25(+) cells were precultured with allogeneic stimulator cells, then sorted into CD150(+) and CD150(-) subsets, allosuppressive activity was contained primarily in the CD150(+) fraction. These cells also suppressed the proliferation of alloantigen-activated autologous T cells, and they could be expanded in vitro without loss of their suppressive capacity. These results suggest that CD150 can be used as a marker for the identification of purified alloantigen-activated CD4(+)25(+) regulatory T cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 41 条
[1]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[2]   SLAM and its role in T cell activation and Th cell responses [J].
Aversa, G ;
Carballido, J ;
Punnonen, J ;
Chang, CCJ ;
Hauser, T ;
Cocks, BG ;
DeVries, JE .
IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02) :202-205
[3]   Inhibition of human CD4+CD25+high regulatory T cell function [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6210-6217
[4]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[5]   A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION [J].
COCKS, BG ;
CHANG, CCJ ;
CARBALLIDO, JM ;
YSSEL, H ;
DEVRIES, JE ;
AVERSA, G .
NATURE, 1995, 376 (6537) :260-263
[6]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[7]   THE HUMAN CD46 MOLECULE IS A RECEPTOR FOR MEASLES-VIRUS (EDMONSTON STRAIN) [J].
DORIG, RE ;
MARCIL, A ;
CHOPRA, A ;
RICHARDSON, CD .
CELL, 1993, 75 (02) :295-305
[8]  
EDINGER M, 2003, NAT MED
[9]   CD4+CD25+ T cells facilitate the induction of T cell anergy [J].
Ermann, J ;
Szanya, V ;
Ford, GS ;
Paragas, V ;
Fathman, CG ;
Lejon, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4271-4275
[10]   CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection [J].
Gross, DA ;
Leboeuf, M ;
Gjata, B ;
Danos, O ;
Davoust, J .
BLOOD, 2003, 102 (13) :4326-4328